Roche announces positive studies of MabThera with subcutaneous injection – pharmabiz.com
Roche announces positive studies of MabThera with subcutaneous injectionpharmabiz.comRoche has reported results from two studies which showed that a fixed dose of MabThera (rituximab) can be administered subcutaneously (SC), potentially allowing patien…
